Sanofi has announced they are discontinuing their Renassist Patient Assistance Program effective December 31, 2017, with the last day to apply being December 1.  Patients currently enrolled in the program will receive their final shipment of free Renvela before the end of the year.

Questions? Call Sanofi customer service at 1-800-633-1610 option 7, option 4.

Through a partnership with Sanofi Renal/Genzyme Corporation, Renvela® (sevelamer carbonate) and IV formulations of Hectorol® (doxercalciferol) injection are available to financially qualified dialysis patients who have no prescription drug coverage. Eligible patients may receive up to a three-month supply and if necessary, may reapply at the end of their grant period.

The American Kidney Fund administers Sanofi Renal/Genzyme’s Renal Patient Assistance Program. Assistance is made possible by a generous product donation from Sanofi Renal/Genzyme. Learn more.